Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response

Critical Reviews in Oncology/hematology
Elena MassaGiovanni Mantovani

Abstract

Aim of the present phase II non-randomized study was to verify whether palonosetron might be able to prevent acute and especially delayed CINV for either HEC or MEC, starting from the second chemotherapy cycle, in patients who had failed to respond to a different antiemetic 5-HT(3) antagonist during the first cycle. Stratification factor was age <65 years vs. > or =65 years of patients included. Forty-seven cancer patients (23 elderly and 24 non-elderly) scheduled to receive HEC or MEC regimens who had experienced CINV grade 3-4 during the first chemotherapy course and for whom the same course of chemotherapy regimen was further scheduled were enrolled. Complete response (CR) and complete control (CC) rates for the acute, delayed and overall phases of CINV were not significantly different between elderly and non-elderly patients. Palonosetron was safe: only grade 1-2 toxicities were observed with a peak of 12.9% for asthenia with no significant difference between elderly and non-elderly patients. In conclusion, single dose palonosetron (250 microg) should be considered a safe and effective second generation 5-HT(3) antagonist in the prevention of nausea and vomiting induced by HEC or MEC, irrespective of patients' age.

References

Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Jun 18, 1998·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·P H De MulderM M Marty
May 29, 2000·The New England Journal of Medicine·UNKNOWN Italian Group for Antiemetic Research
Feb 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P EisenbergA Macciocchi
May 13, 2004·Cancer·Steven M GrunbergGedske Daugaard
Oct 14, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lawrence H EinhornMatti Aapro
May 24, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical OncologySteven M Grunberg
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brigitte Bloechl-DaumJørn Herrstedt
Mar 22, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rudolph M NavariCynthia S Johnson
May 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J HerrstedtUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Jul 16, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bruce FeinbergDeborah Buchner
Mar 3, 2011·International Journal of Clinical Pharmacy·D A PerwitasariHenk-Jan Guchelaar
Oct 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A GiraltM W Schuster
Feb 20, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bart C De Jonghe, Charles C Horn
Oct 27, 2009·Drugs·Lily P H Yang, Lesley J Scott
May 6, 2014·Experimental Brain Research·Erin M RockLinda A Parker
Feb 19, 2013·Expert Opinion on Pharmacotherapy·Alessandra Fabi, Paola Malaguti
May 1, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kaoru KubotaTakashi Ogura
May 29, 2016·Medical Oncology·Seiichiro SuzukiTakafumi Suda
Feb 6, 2010·Expert Review of Anticancer Therapy·Christina Ruhlmann, Jørn Herrstedt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Lawrence H EinhornJ S Bubalo
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Rudolph M NavariCynthia S Johnson
© 2022 Meta ULC. All rights reserved